Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Assets Average (2018 - 2025)

Cue Biopharma's Assets Average history spans 8 years, with the latest figure at $36.9 million for Q4 2025.

  • On a quarterly basis, Assets Average fell 4.08% to $36.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.9 million, a 4.08% decrease, with the full-year FY2025 number at $37.2 million, down 20.61% from a year prior.
  • Assets Average hit $36.9 million in Q4 2025 for Cue Biopharma, up from $36.2 million in the prior quarter.
  • Over the last five years, Assets Average for CUE hit a ceiling of $94.1 million in Q1 2021 and a floor of $27.2 million in Q1 2025.
  • Historically, Assets Average has averaged $65.4 million across 5 years, with a median of $74.2 million in 2023.
  • Biggest five-year swings in Assets Average: surged 42.34% in 2021 and later tumbled 52.85% in 2025.
  • Tracing CUE's Assets Average over 5 years: stood at $81.1 million in 2021, then rose by 3.27% to $83.8 million in 2022, then decreased by 22.18% to $65.2 million in 2023, then tumbled by 40.96% to $38.5 million in 2024, then decreased by 4.08% to $36.9 million in 2025.
  • Business Quant data shows Assets Average for CUE at $36.9 million in Q4 2025, $36.2 million in Q3 2025, and $31.5 million in Q2 2025.